1,678 results on '"Van Laere, Koen"'
Search Results
202. List of Contributors
203. Parametric imaging and quantitative analysis of the PET amyloid ligand [18F]flutemetamol
204. Regional Brain Activity in Functional Dyspepsia: A H 215O-PET Study on the Role of Gastric Sensitivity and Abuse History
205. Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study
206. Changes in the language system as amyloid-β accumulates
207. Rigid motion tracking using moments of inertia in TOF-PET brain studies
208. E01 Widespread loss of presynaptic terminal marker SV2A in early huntington disease
209. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
210. Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study
211. Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer
212. Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI
213. Functional brain changes underlying irritability in premanifest Huntingtonʼs disease
214. Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
215. Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [18F]MK-9470 PET Study
216. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users
217. Psychotic Reactivity to Daily Life Stress and the Dopamine System: A Study Combining Experience Sampling and [18F]fallypride Positron Emission Tomography
218. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging
219. Long term clinical outcome of peripheral nerve stimulation in patients with chronic peripheral neuropathic pain
220. Additional file 1 of Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer
221. sj-pdf-1-jcb-10.1177_0271678X211047759 - Supplemental material for Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study
222. Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth.
223. Impact of meningeal uptake and partial volume correction techniques on [ 18 F]MK-6240 binding in aMCI patients and healthy controls.
224. Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects
225. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database
226. Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging
227. A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
228. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis
229. Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model
230. List of ContributorS
231. Brain Imaging of Cannabinoid Receptors
232. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats
233. Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
234. Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain
235. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
236. Autoimmune-mediated encephalitis
237. Characterization of the Inflammatory Response in a Photothrombotic Stroke Model by MRI: Implications for Stem Cell Transplantation
238. Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study
239. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [ 18F]MK-9470 PET
240. Labelling and biological evaluation of [ 11C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor
241. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [ 18F]FECT
242. The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake
243. Neuronuclear Assessment of Patients With Epilepsy
244. Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
245. Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding: An In Vivo Micro-PET Study in the Rat Using [18F]MK-9470
246. The effect of anaesthesia on [18F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain
247. Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI
248. Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
249. Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson’s disease discerned with μSPECT and quantitative MRI
250. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.